ESC 365 - Is there an association of anthracyclines with HFrEF and/or HFpEF in patients treated for breast cancer or lymphoma after 30 years of follow-up? Insights from the Rochester epidemiology project

ESC Premium Access

Is there an association of anthracyclines with HFrEF and/or HFpEF in patients treated for breast cancer or lymphoma after 30 years of follow-up? Insights from the Rochester epidemiology project

Session: Miscellaneous clinical studies in heart failure (3)

Topic: Cardiotoxicity of Drugs and Other Therapies

Speaker: Doctor E. Tellez Garcia (Rochester, US)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Eduardo Tellez Garcia

Rochester (United States of America)

0 follower

4 more presentations in this session

A new heart transplant resource: DBD donor with out-of-hospital cardiac arrest

Speaker: Doctor G. Fischetti (Bari, IT)

Circulating metabolites in patients with chronic heart failure are related to increased lipid utilisation but not to gut microbiota alterations

Speaker: Doctor A. Nendl (Oslo, NO)

Ivabradine prevents doxorubicin-induced cardiotoxicity via attenuating mitochondrial dysfunction and mitochondrial dynamic imbalance in H9C2 cells and rats

Speaker: Doctor A. Sripusanapan (Chiang Mai, TH)

Adipose tissue/ heart lipid transport determines cardiac diastolic function

Speaker: Mr G. Trimarchi (Berlin, DE)

Access the full session

Miscellaneous clinical studies in heart failure (3)

Speakers: Doctor E. Tellez Garcia, Doctor G. Fischetti, Doctor A. Nendl, Doctor A. Sripusanapan, Mr G. Trimarchi

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources